MONDAY, Jan. 10, 2022 (HealthDay News) — For people newly diagnosed with advanced melanoma, a combination of two immunotherapy drugs can double the amount of time their cancer remains progression-free, a clinical trial has found. The treatment combines two drugs known as immune checkpoint inhibitors. One, called nivolumab (Opdivo), isContinue Reading

MONDAY, Jan. 10, 2022 (HealthDay News) — Vaccination is still the best way to protect someone from COVID-19, but new research suggests that immune system activation of T-cells by common colds may offer some cross-protection. The study might also provide a blueprint for a second-generation, universal vaccine that could preventContinue Reading

THURSDAY, Jan. 6, 2022 (HealthDay News) — A medication that acts on certain brain receptors can temporarily ease visual-processing problems in some adults with autism, a small study has found. Researchers said it’s far too early to know whether the drug, arbaclofen, could prove useful in managing those visual issues.Continue Reading

TUESDAY, Jan. 4, 2022 (HealthDay News) — Many insured cancer patients still experience serious money problems linked to their illness, new research affirms. For example, nearly 3 out of 4 insured patients with colon cancer have major financial hardship in the year after their diagnosis, which affects their social functioningContinue Reading

MONDAY, Jan. 3, 2022 (HealthDay News) — An international trial found that a once-a-day antiretroviral medication for kids with HIV is not only cheap and easy to take, but also better at suppressing HIV than standard treatments. “Our findings provide strong evidence for the global rollout of dolutegravir for childrenContinue Reading